Associations between <i>CCL5</i> haplotype C and D and HCV serostatus among people who inject drugs by univariate and multivariate models.

<p>Associations between <i>CCL5</i> haplotype C and D and HCV serostatus among people who inject drugs by univariate and multivariate models.</p

Factors influencing HCV and HIV serostatus by univariate analyses.

#<p>The OR was estimated by every increased year of age;</p>*<p>The OR was estimated by every increased year of IVDU use;</p>&<p>The median of <i>CCL3L1</i> copy number is 2 copies in our studied IDUs.</p

Association of <i>CCR5</i> HHG*1 with HCV or HIV serostatus.

#<p>Co-variates: HBV serostatus, <i>CCL3L1</i> copy number, IVDU duration and HBV serostatus.</p

The distribution of <i>CCR5</i> haplotypes among IDUs and blood donors.

<p><i>CCR5</i> haplotype frequency among (<b>A</b>) IDUs vs. blood donors, (<b>B</b>) HCV+vs. HCV- IDUs, and (<b>C</b>) HIV- vs. HIV+IDUs. HHB and HHD are absent in the study populations. Frequency of (<b>D</b>) <i>CCR5</i> HHG*1 haplotype and (<b>E</b>) <i>CCR5</i> HHG*1-containing genotypes in IDUs by HCV and HIV serostatus.</p

HIV, HCV and HBV serostatus among 373 IDUs from Estonia in 2006–2007^*.

*<p>HBV serostatus was unknown for 7 individuals.</p